Sarah J. Neal

发表

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes

N. Brandon, S. Moss, Z. Hughes, 2012, Translational Psychiatry.

CLK2 inhibition ameliorates autistic features associated with SHANK3 deficiency

Jeffrey A. Porter, R. Dolmetsch, T. Bouwmeester, 2016, Science.

The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?

J. Dwyer, L. Di, A. Randall, 2011, Journal of Pharmacology and Experimental Therapeutics.

The BTBR Mouse Model of Autism Spectrum Disorders Has Learning and Attentional Impairments and Alterations in Acetylcholine and Kynurenic Acid in Prefrontal Cortex

S. McTighe, Z. Hughes, Daniel G Smith, 2013, PloS one.

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression

J. Brennan, J. Dwyer, R. Ring, 2013, Neuropharmacology.

Phosphodiesterase 11A in brain is enriched in ventral hippocampus and deletion causes psychiatric disease-related phenotypes

T. Comery, S. Grauer, J. Brennan, 2010, Proceedings of the National Academy of Sciences.

Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation

C. Beyer, J. Dwyer, S. Rosenzweig-Lipson, 2010, Psychopharmacology.

Characterization of a Novel M1 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator Radioligand, [3H]PT-1284

J. Edgerton, S. Grimwood, D. Smith, 2016, Molecular Pharmacology.

Acid sensing ion channel (ASIC) inhibitors exhibit anxiolytic-like activity in preclinical pharmacological models

C. Beyer, J. Dwyer, J. Dunlop, 2009, Psychopharmacology.